| 000 | 01451 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517163048.0 | ||
| 264 | 0 | _c20180430 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a1476-5381 | ||
| 024 | 7 |
_a10.1111/bph.13945 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLuangmonkong, Theerut | |
| 245 | 0 | 0 |
_aEvaluating the antifibrotic potency of galunisertib in a human ex vivo model of liver fibrosis. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cSep 2017 |
||
| 300 |
_a3107-3117 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aPyrazoles _xchemistry |
| 650 | 0 | 4 |
_aQuinolines _xchemistry |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSmad2 Protein _xantagonists & inhibitors |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aSuriguga, Su | |
| 700 | 1 | _aBigaeva, Emilia | |
| 700 | 1 | _aBoersema, Miriam | |
| 700 | 1 | _aOosterhuis, Dorenda | |
| 700 | 1 | _ade Jong, Koert P | |
| 700 | 1 | _aSchuppan, Detlef | |
| 700 | 1 | _aMutsaers, Henricus A M | |
| 700 | 1 | _aOlinga, Peter | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 174 _gno. 18 _gp. 3107-3117 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bph.13945 _zAvailable from publisher's website |
| 999 |
_c27352259 _d27352259 |
||